US

Ulrich Sensfuss

NA Novo Nordisk A/S: 1 patents #35 of 144Top 25%
Overall (2018): #203,778 of 503,207Top 45%
1
Patents 2018

Issued Patents 2018

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
9988430 Stable GLP-1 based GLP-1/glucagon receptor co-agonists Steffen Reedtz-Runge, Thomas Kruse, Jane Spetzler, Henning Thoegersen, Christian Wenzel Tornoee +1 more 2018-06-05